Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP543563.RAQrC-XvpOYKcgRw-rv7gXbfullCatg0NkZIi5PbHAJ5U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP543563.RAQrC-XvpOYKcgRw-rv7gXbfullCatg0NkZIi5PbHAJ5U130_assertion type Assertion NP543563.RAQrC-XvpOYKcgRw-rv7gXbfullCatg0NkZIi5PbHAJ5U130_head.
- NP543563.RAQrC-XvpOYKcgRw-rv7gXbfullCatg0NkZIi5PbHAJ5U130_assertion description "[Semi-quantitative RT-PCR, Western blotting and immunohistochemistry indicate that leiomyoma and myometrium expresses receptor-activated Smad3, common Smad4 and inhibitory Smad7, with elevated expression of Smad3, Smad4 and phosphorylated Smad3 (pSmad3) as well as TGF-betaR type I and type II in leiomyoma compared to myometrium (P<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP543563.RAQrC-XvpOYKcgRw-rv7gXbfullCatg0NkZIi5PbHAJ5U130_provenance.
- NP543563.RAQrC-XvpOYKcgRw-rv7gXbfullCatg0NkZIi5PbHAJ5U130_assertion evidence source_evidence_literature NP543563.RAQrC-XvpOYKcgRw-rv7gXbfullCatg0NkZIi5PbHAJ5U130_provenance.
- NP543563.RAQrC-XvpOYKcgRw-rv7gXbfullCatg0NkZIi5PbHAJ5U130_assertion SIO_000772 14604812 NP543563.RAQrC-XvpOYKcgRw-rv7gXbfullCatg0NkZIi5PbHAJ5U130_provenance.
- NP543563.RAQrC-XvpOYKcgRw-rv7gXbfullCatg0NkZIi5PbHAJ5U130_assertion wasDerivedFrom befree-20150227 NP543563.RAQrC-XvpOYKcgRw-rv7gXbfullCatg0NkZIi5PbHAJ5U130_provenance.
- NP543563.RAQrC-XvpOYKcgRw-rv7gXbfullCatg0NkZIi5PbHAJ5U130_assertion wasGeneratedBy ECO_0000203 NP543563.RAQrC-XvpOYKcgRw-rv7gXbfullCatg0NkZIi5PbHAJ5U130_provenance.